Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Greene

Showing results (311-320 of 464) with videos related to

Pageof 47
Sort By:
Oncoimmunology|April 11, 2018
A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γHongtao Zhang, Lian Lam, Yasuhiro Nagai, et al.
DNA and Cell Biology|December 14, 1999
The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expressionJ Roland, A Berezov, M I Greene, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agentDatta E Ponde, ZiFen Su, Alan Berezov, et al.
Clinical Immunology and Immunopathology|August 1, 1986
Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infectionI K Sandstrom, C S Foster, P A Wells, et al.
The Journal of Biological Chemistry|January 5, 1999
Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomesX Qian, D M O'Rourke, Z Fei, et al.
Oncogene|August 1, 1994
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapiesW C Dougall, X Qian, N C Peterson, et al.
Oncotarget|February 10, 2018
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77Xi Chen, Yasuhiro Nagai, Zhiqiang Zhu, et al.
Immunological Reviews|December 1, 1987
Receptor systems in tissues of the nervous systemM I Greene, Y Kokai, G N Gaulton, et al.
Community Mental Health Journal|December 13, 2005
Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatmentMark G Winiarski, Lori I Greene, Alec L Miller, et al.
The Journal of Experimental Medicine|February 1, 1981
Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cellsM H Dietz, M S Sy, B Benacerraf, et al.
Pageof 47

Showing results (311-320 of 464) with videos related to

Sort By:
Pageof 47
Oncoimmunology|April 11, 2018
A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γHongtao Zhang, Lian Lam, Yasuhiro Nagai, et al.
DNA and Cell Biology|December 14, 1999
The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expressionJ Roland, A Berezov, M I Greene, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agentDatta E Ponde, ZiFen Su, Alan Berezov, et al.
Clinical Immunology and Immunopathology|August 1, 1986
Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infectionI K Sandstrom, C S Foster, P A Wells, et al.
The Journal of Biological Chemistry|January 5, 1999
Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomesX Qian, D M O'Rourke, Z Fei, et al.
Oncogene|August 1, 1994
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapiesW C Dougall, X Qian, N C Peterson, et al.
Oncotarget|February 10, 2018
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77Xi Chen, Yasuhiro Nagai, Zhiqiang Zhu, et al.
Immunological Reviews|December 1, 1987
Receptor systems in tissues of the nervous systemM I Greene, Y Kokai, G N Gaulton, et al.
Community Mental Health Journal|December 13, 2005
Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatmentMark G Winiarski, Lori I Greene, Alec L Miller, et al.
The Journal of Experimental Medicine|February 1, 1981
Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cellsM H Dietz, M S Sy, B Benacerraf, et al.
Pageof 47